VMP 41877611000001100

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Ethinylestradiol 35microgram / Norgestimate 250microgram tablets
BNF code 0703010G0AAACAC
Virtual Therapeutic Moiety Ethinylestradiol + Norgestimate
Date identifier became valid 26 May 2023
Previous product identifier 326364003
Abbreviated name Ethinylestradiol 35microgram / Norgestimate 250microgram tab
Basis of preferred name Other
Date of name applicability 25 Jun 2010
Previous name Norgestimate 250microgram / Ethinylestradiol 35microgram tablets
Basis of previous name Other
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Norgestimate
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 250.000
Strength value numerator unit microgram
Virtual Product Ingredient
Ingredient Ethinylestradiol
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 35.000
Strength value numerator unit microgram
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Cilique 250microgram/35microgram tablets (Gedeon Richter (UK) Ltd)
Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)
Virtual Medicinal Product Packs
Ethinylestradiol 35microgram / Norgestimate 250microgram tablets 126 tablet
Ethinylestradiol 35microgram / Norgestimate 250microgram tablets 63 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback